NCT05621902View on ClinicalTrials.gov

Web-based Symptom Monitoring and Survival in Advanced Stage Lung Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

398

Participants

Timeline

Start Date

November 18, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2027

Conditions
Lung Cancer
Interventions
OTHER

Weekly symptom monitoring

Patients randomized to the intervention arm will be invited to respond to a web-based weekly 11-item signs- and symptoms questionnaire

All Listed Sponsors
collaborator

Uppsala University Hospital

OTHER

collaborator

Gävle Hospital

OTHER

lead

Mats Lambe

OTHER

NCT05621902 - Web-based Symptom Monitoring and Survival in Advanced Stage Lung Cancer | Biotech Hunter | Biotech Hunter